Empirical Wealth Management
WST icon

Empirical Wealth Management’s West Pharmaceutical WST Stock Holding History

Empirical Wealth Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.44M Buy
3,892
+1,519
+64% +$536K 0.02% 373
2026
Q2 		$852K Buy
2,373
+1,137
+92% +$348K 0.01% 453
2026
Q1 		$310K Buy
+1,236
New +$308K 0.01% 779

Other funds holding WST

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Border to Coast Pensions Partnership
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return

Empirical Wealth Management's WST Position: Q3 2026 in Review

Empirical Wealth Management increased its West Pharmaceutical (WST) stake by 64% in Q3 2026, buying an estimated $536K and bringing the position to 3,892 shares worth $1.44M. The position accounts for 0.02% of the portfolio, ranked #373.

Empirical Wealth Management first reported a position in WST in Q1 2026 and has held it in 3 quarters since. 472 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Empirical Wealth Management held 3,892 shares of West Pharmaceutical worth $1.44M as of Q3 2026.
  • Empirical Wealth Management bought 1,519 West Pharmaceutical shares in Q3 2026, an estimated $536K.
  • West Pharmaceutical made up 0.02% of Empirical Wealth Management's portfolio in Q3 2026, its #373 holding.
  • Empirical Wealth Management first reported a position in West Pharmaceutical in Q1 2026 and has held it in 3 quarters since.
  • 472 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Empirical Wealth Management's 13F filing for Q3 2026, filed 27 Oct 2026.